167 filings
Page 3 of 9
6-K/A
agxkh6en
14 Aug 23
Current report (foreign) (amended)
4:38pm
6-K/A
vdgpv9lkbpxnugqn
14 Aug 23
Current report (foreign) (amended)
4:29pm
6-K
7z1di9kiqup z1adk11
9 Aug 23
Immunoprecise Antibodies LTD. 6-K
9:15am
EFFECT
eejb7rqr
17 Jul 23
Notice of effectiveness
12:15am
6-K
5eyv7obisiirq99l9v
14 Jul 23
Immunoprecise Antibodies LTD. 6-K
8:10am
CORRESP
5pvwz i1pfydehbw
13 Jul 23
Correspondence with SEC
12:00am
UPLOAD
5disxm
12 Jul 23
Letter from SEC
12:00am
F-3
4i2ynqlm4m3t 3pmf
10 Jul 23
Shelf registration (foreign)
7:04pm
40-F
pq5p83t
10 Jul 23
Annual report (Canada)
4:32pm
SC 13D
ruwdxaf
7 Jul 23
ImmunoPrecise Antibodies / INGALLS & SNYDER ownership change
3:22pm
6-K
t3r il4d952z
7 Jul 23
Immunoprecise Antibodies LTD. 6-K
8:36am
6-K
357vwow065jll
29 Jun 23
The Company to host an earnings conference call via webcast
9:01am
6-K
stnzyh23272h o3
13 Jun 23
Immunoprecise Antibodies LTD. 6-K
7:41am
6-K
l8o7n96y7isioml6ujmb
6 Jun 23
Immunoprecise Antibodies LTD. 6-K
8:09am
6-K
i72x3b8
30 May 23
Immunoprecise Antibodies LTD. 6-K
8:04am
6-K
jc257z1
17 May 23
Immunoprecise Antibodies LTD. 6-K
11:35am
6-K
36j47uj4
24 Apr 23
Current report (foreign)
10:01am
6-K
xvi5 8tc4j
30 Mar 23
Form 51-102F3 MATERIAL CHANGE REPORT
12:53pm
6-K
bw2m8w
30 Mar 23
Immunoprecise Antibodies LTD. 6-K
8:04am
6-K
jsv49oj lie0njl
27 Mar 23
Immunoprecise Antibodies LTD. 6-K
9:05am